Skip to main content

Table 5 Cross-sectional validity for individuals with an exacerbation of asthma at the follow-up survey* (n = 143)

From: Comparing a disease-specific and a generic health-related quality of life instrument in subjects with asthma from the general population

Instrument

AQLQ

       

Validation measure

Activity limitation

Symptoms

Emotional function

Environmental exposure

    

Severity of asthma

-0.27

-0.34

-0.33

-0.28

    

Respiratory symptoms

-0.49

-0.62

-0.43

-0.52

    

Exercise limitation

-0.32

-0.39

-0.32

-0.30

    

Professional or leisure limitation due to asthma?

-0.34

-0.34

-0.24

-0.30

    

Depression

-0.21

-0.13

-0.09

-0.15

    

Smoking

 

   Current

-0.05

-0.10

-0.08

-0.13

 

   Current or former

-0.08

-0.21

-0.14

-0.14

    

FEV 1 (% of predicted value)

0.34

0.27

0.34

0.29

    

FEF 25–75 (% of predicted value)

0.24

0.12

0.21

0.18

    
 

SF-36

       
 

Physical functioning

Role physical

Bodily pain

General health

Vitality

Social functioning

Role emotional

Mental health

Severity of asthma

-0.24

-0.25

-0.18

-0.25

-0.03

-0.16

-0.12

-0.12

Respiratory symptoms

-0.38

-0.29

-0.31

-0.26

-0.30

-0.20

-0.20

-0.29

Exercise limitation

-0.42

-0.20

-0.19

-0.16

-0.27

-0.10

-0.11

-0.18

Professional or leisure limitation due to asthma?

-0.34

-0.38

-0.28

-0.32

-0.19

-0.20

-0.22

-0.15

Depression

-0.26

-0.25

-0.33

-0.38

-0.27

-0.38

-0.35

-0.25

Smoking

 

   Current

0.00

0.02

-0.11

0.01

0.03

0.04

0.09

0.04

   Current or former

-0.11

-0.12

-0.23

0.11

-0.14

-0.12

-0.01

0.03

FEV 1 (% of predicted value)

0.57

0.32

0.18

0.12

0.06

0.18

0.21

0.05

FEF 25–75 (% of predicted value)

0.48

0.33

0.30

0.09

0.06

0.21

0.23

0.03

  1. * Selection criteria are described in the Methods section